In the News

04/21/2017 12:00 AM  | Investor's Business Daily
04/11/2017 12:00 AM  | WOR 710
03/16/2017 12:00 AM  | Medical Marketing & Media
02/27/2017 12:00 AM  | Pittsburgh Tribune
02/21/2017 12:00 AM  | Wall Street Journal
02/15/2017 12:00 AM  | Forbes
02/10/2017 12:00 AM  | Morning Consult
12/18/2016 12:00 AM  | USA Today
Sign Up for Our Email Newsletter

RECENT NEWS

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta...  Read more

FDA  Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15
  • NEWSY
  • 01/04/2022 12:00 AM

FDA Authorizes Pfizer Covid-19 Vaccine Booster for Ages 12-15

CMPI's Peter Pitts discusses FDA approval of Pfizer COVID vaccine booster for children ages 12-15...  Read more

Should We Rethink The FDA Commissionership?

Should We Rethink The FDA Commissionership?

When one considers the FDA’s mission—to independently protect consumers and advance the public health—it is not at all cl...  Read more

DRUGWONKS BLOG